Recent machine-extracted executive movements from SEC 8-K Item 5.02 filings, source-linked. Every card cites the SEC source.
Showing 9501–9550 of 35188
On June 7, 2024, Radclyffe Roberts also provided notice of his resignation as member of the Board and as a member of the Board’s Compensation Committee (the “Compensation Committee”) as well as a member and chair of the Board’s M&A Committee.
On June 7, 2024, Inchul Chung provided notice of his resignation as a member of the Board of Directors (the “Board”) of Bellevue Life Sciences Acquisition Corp. (the “Company”) and as a member of the Board’s Audit Committee (the “Audit Committee”).
On June 6, 2024, in connection with the IPO, Kwan Sun, James Zhang and Ning Ma were appointed to the board of directors of the Company (the “Board”).
On June 6, 2024, in connection with the IPO, Kwan Sun, James Zhang and Ning Ma were appointed to the board of directors of the Company (the “Board”).
On June 6, 2024, in connection with the IPO, Kwan Sun, James Zhang and Ning Ma were appointed to the board of directors of the Company (the “Board”).
Mark Gerhard, Riaan Hodgson, Robert Foresman, Michael Jesselson and Mickie Rosen were appointed to the board of directors of the Company.
Mark Gerhard, Riaan Hodgson, Robert Foresman, Michael Jesselson and Mickie Rosen were appointed to the board of directors of the Company.
Mark Gerhard, Riaan Hodgson, Robert Foresman, Michael Jesselson and Mickie Rosen were appointed to the board of directors of the Company.
Mark Gerhard, Riaan Hodgson, Robert Foresman, Michael Jesselson and Mickie Rosen were appointed to the board of directors of the Company.
Mark Gerhard, Riaan Hodgson, Robert Foresman, Michael Jesselson and Mickie Rosen were appointed to the board of directors of the Company.
On June 11, 2024, Gary Pace notified the Board of Directors (the “Board”) of Pacira BioSciences, Inc. (the “Company”) of his intent to retire from the Board, effective June 30, 2024.
On May 21, 2024, the Company appointed Yang Huan as a member of the Company’s Board of Directors.
On May 21, 2024, China Foods Holdings, Ltd. (the “Company”) appointed Kong Liqi as a member of the Company’s Board of Directors.
elected James Shannon, M.D., as a Class I director of the Company
On June 12, 2024, Mr. C. Dean Scarborough, a member of the board of directors (the “Board”) of 1st Franklin Financial Corporation, retired from the Board.
Effective June 10, 2024, the Board of Directors (the “Board”) of Tyson Foods, Inc. (the “Company”) increased the size of the Board from fourteen to fifteen directors, and appointed Maria N. Martinez as a member of the Board.
On June 11, 2024, Lisa Cummins notified WiSA Technologies, Inc. (the “Company”) of her decision to resign from the Company’s board of directors (the “Board”), effective June 12, 2024.
On June 12, 2024, the Board, pursuant to its powers under the Company’s bylaws, appointed Kimberly Briskey as a member of the Board to replace Ms. Cummins, effective June 12, 2024.
Effective June 11, 2024, Illumina, Inc., as sole member of GRAIL, LLC (the “Company”), established a board of directors of the Company (the “Board”) and appointed each of Charles Dadswell, Ankur Dhingra and William (Bill) Chase (together, the “Directors”) to the Board.
Effective June 11, 2024, Illumina, Inc., as sole member of GRAIL, LLC (the “Company”), established a board of directors of the Company (the “Board”) and appointed each of Charles Dadswell, Ankur Dhingra and William (Bill) Chase (together, the “Directors”) to the Board.
Pursuant to the Plan, on the Effective Date, Paul Keglevic, Paul Aronzon, Alex Clavel, Elizabeth LaPuma, Henry S. Miller, David Tolley and Vikas Parekh ceased to be directors of the Company and were replaced by Anant Yardi, Jason Yardi, Adnan Ahmad, Arnold Brier, Daniel Ehrmann and Jagannath Iyer.
Pursuant to the Plan, on the Effective Date, Paul Keglevic, Paul Aronzon, Alex Clavel, Elizabeth LaPuma, Henry S. Miller, David Tolley and Vikas Parekh ceased to be directors of the Company and were replaced by Anant Yardi, Jason Yardi, Adnan Ahmad, Arnold Brier, Daniel Ehrmann and Jagannath Iyer.
Pursuant to the Plan, on the Effective Date, Paul Keglevic, Paul Aronzon, Alex Clavel, Elizabeth LaPuma, Henry S. Miller, David Tolley and Vikas Parekh ceased to be directors of the Company and were replaced by Anant Yardi, Jason Yardi, Adnan Ahmad, Arnold Brier, Daniel Ehrmann and Jagannath Iyer.
Pursuant to the Plan, on the Effective Date, Paul Keglevic, Paul Aronzon, Alex Clavel, Elizabeth LaPuma, Henry S. Miller, David Tolley and Vikas Parekh ceased to be directors of the Company and were replaced by Anant Yardi, Jason Yardi, Adnan Ahmad, Arnold Brier, Daniel Ehrmann and Jagannath Iyer.
Pursuant to the Plan, on the Effective Date, Paul Keglevic, Paul Aronzon, Alex Clavel, Elizabeth LaPuma, Henry S. Miller, David Tolley and Vikas Parekh ceased to be directors of the Company and were replaced by Anant Yardi, Jason Yardi, Adnan Ahmad, Arnold Brier, Daniel Ehrmann and Jagannath Iyer.
Pursuant to the Plan, on the Effective Date, Paul Keglevic, Paul Aronzon, Alex Clavel, Elizabeth LaPuma, Henry S. Miller, David Tolley and Vikas Parekh ceased to be directors of the Company and were replaced by Anant Yardi, Jason Yardi, Adnan Ahmad, Arnold Brier, Daniel Ehrmann and Jagannath Iyer.
Pursuant to the Plan, on the Effective Date, Paul Keglevic, Paul Aronzon, Alex Clavel, Elizabeth LaPuma, Henry S. Miller, David Tolley and Vikas Parekh ceased to be directors of the Company and were replaced by Anant Yardi, Jason Yardi, Adnan Ahmad, Arnold Brier, Daniel Ehrmann and Jagannath Iyer.
Pursuant to the Plan, on the Effective Date, Paul Keglevic, Paul Aronzon, Alex Clavel, Elizabeth LaPuma, Henry S. Miller, David Tolley and Vikas Parekh ceased to be directors of the Company and were replaced by Anant Yardi, Jason Yardi, Adnan Ahmad, Arnold Brier, Daniel Ehrmann and Jagannath Iyer.
Pursuant to the Plan, on the Effective Date, Paul Keglevic, Paul Aronzon, Alex Clavel, Elizabeth LaPuma, Henry S. Miller, David Tolley and Vikas Parekh ceased to be directors of the Company and were replaced by Anant Yardi, Jason Yardi, Adnan Ahmad, Arnold Brier, Daniel Ehrmann and Jagannath Iyer.
Pursuant to the Plan, on the Effective Date, Paul Keglevic, Paul Aronzon, Alex Clavel, Elizabeth LaPuma, Henry S. Miller, David Tolley and Vikas Parekh ceased to be directors of the Company and were replaced by Anant Yardi, Jason Yardi, Adnan Ahmad, Arnold Brier, Daniel Ehrmann and Jagannath Iyer.
Upon his appointment as Chief Executive Officer, John C. Santora will join the board as a director.
Pursuant to the Plan, on the Effective Date, Paul Keglevic, Paul Aronzon, Alex Clavel, Elizabeth LaPuma, Henry S. Miller, David Tolley and Vikas Parekh ceased to be directors of the Company and were replaced by Anant Yardi, Jason Yardi, Adnan Ahmad, Arnold Brier, Daniel Ehrmann and Jagannath Iyer.
Pursuant to the Plan, on the Effective Date, Paul Keglevic, Paul Aronzon, Alex Clavel, Elizabeth LaPuma, Henry S. Miller, David Tolley and Vikas Parekh ceased to be directors of the Company and were replaced by Anant Yardi, Jason Yardi, Adnan Ahmad, Arnold Brier, Daniel Ehrmann and Jagannath Iyer.
Pursuant to the Plan, on the Effective Date, Paul Keglevic, Paul Aronzon, Alex Clavel, Elizabeth LaPuma, Henry S. Miller, David Tolley and Vikas Parekh ceased to be directors of the Company and were replaced by Anant Yardi, Jason Yardi, Adnan Ahmad, Arnold Brier, Daniel Ehrmann and Jagannath Iyer.
On June 7, 2024, the board of directors (the “Board”) of Vera Therapeutics, Inc. (the “Company”) appointed Christy Oliger to the Board, effective immediately.
On June 6, 2024, Brett P. Seabert, serving as a Director and Audit Committee Chair on the Board of Directors (the “Board”) of Rocky Mountain Chocolate Factory, Inc. (the “Company”), notified the Board of his intention to resign effective June 6, 2024.
On June 12, 2024, the Company’s Board of Directors appointed Alan J. Sweet as a new director of the Company, effective immediately.
Cole Johnson was appointed as a director of the Company
On June 7, 2024, Michael Hartmeier submitted his resignation as a member of the Board of Directors (the "Board") of Full House Resorts, Inc. (the "Company"), effective immediately.
Gary S. Pinkus was appointed to serve as a Class I director of Bloom Energy effective June 15, 2024
Upon the closing of the Offering and the resulting reduction in the outstanding shares of Class C common stock and Class D common stock, on June [12], 2024, Sean Sullivan, who served as the remaining Class C Director, resigned from the Board in accordance with the Certificate of Incorporation and the Stockholders Agreement.
On June 10, 2024, Anat Ashkenazi, a director of Maravai LifeSciences Holdings, Inc. (the “Company”), informed the Board of Directors of the Company (the “Board”) that she plans to resign from the Board effective as of July 31, 2024, in consideration of the time commitments associated with her pending appointment as Chief Financial Officer of Alphabet Inc.
appointed Maria Castañón Moats to fill the vacancy created by the expansion of the Board, each effective as of July 1, 2024.
On June 9, 2024, Mr. Scipio “Max” Carnecchia tendered his resignation as a member of the Board of Directors of Mitek Systems, Inc. (the “Company”) effective immediately.
Alfred E. Osborne, Jr. retired as a director of the Company effective June 11, 2024
On June 10, 2024, the Board of Directors (the “ Board ”) of Bread Financial Holdings, Inc. (the “ Company ”) voted to increase the size of the Board to ten directors and appointed Praniti Lakhwara as a director and member of the Risk & Technology Committee, all effective as of June 10, 2024.
one member, Michael Nierenberg, that was nominated by Rithm
one member, Daniel Hoffman, that is a newly elected independent director of the Company
On June 9, 2024, Barbara Nelson, a member of the Board of Directors of the Company (the “Board”), the Chair of the Nominating and Governance Committee of the Board and a member of the Audit Committee of the Board, notified the Company of her decision not to stand for reelection when her current term expires at the Company’s 2024 Annual Meeting of Stockholders.
the Board elected Gary S. Pinkus to the Board, effective immediately
Recent executive movements from 8-K Item 5.02 filings, source-linked. Cards are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.